Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study. (Q46902513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Luigi Rigacci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Luca Nassi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Renato Alterini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Valentina Carrai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Giovanni Longo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Franco Bernardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Varesco Martini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

22-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review

15 January 2020

cites work

1 reference

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide

21 January 2018

1 reference

Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

21 January 2018

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.

21 January 2018

1 reference

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

21 January 2018

1 reference

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000089461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16424645%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference